Patient and ophthalmologist attitudes concerning compliance and dosing in glaucoma treatment

Journal of Ocular Pharmacology and Therapeutics

Volumn 20, Issue 6, 2004, Pages 461-469

  Stewart, William C ^a,b   Konstas, Anastasios G P ^c   Pfeiffer, Norbert ^d  

^a University of South Carolina   (United States)

^b UNIVERSITY OF SOUTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c AHEPA UNIVERSITY HOSPITAL   (Greece)

^d JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRIMONIDINE; CARBONATE DEHYDRATASE INHIBITOR; DORZOLAMIDE; LATANOPROST; PILOCARPINE; TIMOLOL;

ARTICLE; CONTROLLED STUDY; DOCTOR PATIENT RELATION; DRUG DOSE REGIMEN; GLAUCOMA; HEALTH SURVEY; HUMAN; INTERVIEW; INTRAOCULAR PRESSURE; MAJOR CLINICAL STUDY; MEDICAL PRACTICE; MONOTHERAPY; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SATISFACTION; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; TREATMENT OUTCOME; VISUAL IMPAIRMENT;

ATTITUDE TO HEALTH; DATA COLLECTION; EUROPE; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; OPHTHALMIC SOLUTIONS; PATIENT COMPLIANCE; PATIENT EDUCATION; PHYSICIAN-PATIENT RELATIONS; TIME FACTORS;

EID: 10344256141     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2004.20.461     Document Type: Article

References (22)

1. Konstas, A.G.P., Maskaleris, G., Gratsonidis, C., and Sardelli, C. Compliance and viewpoint of glaucoma patients in Greece. Eye 14:752-756, 2000.
2. Stewart, W.C., Chorak, R.P., Hunt, H.H., and Sethuraman, G. Factors associated with visual loss in patients with advanced glaucomatous changes in the optic nerve head. Am. J. Ophthalmol. 116:176-181, 1993.
3. Zimmermann, T., and Zalta, A. Facilitating patient compliance in glaucoma therapy. Surv. Ophthalmol. Suppl. 28:252-257, 1983.
4. Bloch, S., Rosenthal, A.R., Friedman, L., and Caldarolla, P. Patient compliance in glaucoma. Br. J. Ophthalmol. 61:531-534, 1977.
5. Patel, S.C., and Spaeth, G.L. Compliance in patients prescribed eyedrops for glaucoma. Ophthalmic Surg. 26:233-236, 1995.
6. Kass, M.A., Meltzer, D.W., Gordon, M., Cooper, D., and Goldberg, J.J. Compliance with topical pilocarpine treatment. Am. J. Ophthalmol. 101:515-523, 1986.
7. Kass, M.A., Gordon, M., Morley, Jr., R.E., Meltzer, D.W., and Goldberg, J.J. Compliance with topical timolol treatment. Am. J. Ophthalmol. 103:188-193, 1987.
8. Kass, M.A., Gordon, M., and Meltzer, D.W. Can ophthalmologists correctly identify patients defaulting from pilocarpine treatment? Am. J. Ophthalmol. 101:524-530, 1986.
9. Book, S.A. Essentials of statistics. New York: McGraw-Hill Book Company, 1978:117-122, 205-215.
10. Blackwell, B. Drug therapy: Patient compliance. N. Engl. J. Med. 289:249-252, 1973.
11. Granström, P.A. Glaucoma patients not compliant with their drug therapy: Clinical and behavioral aspects. Br. J. Ophthalmol. 66:464-470, 1982.
12. Spaeth, G.L. "Noncompliance" - Not a patient problem, but rather a sign of a sick doctor-patient relationship. Ophthalmic. Surg. 26:189-193, 1995.
13. Demailly, P., Zoute, C., and Castro, D. Personalities and chronic glaucoma. J. Fr. Ophthalmol. 12:595-601, 1989.
14. Vincent, P.A. Patients' viewpoint of glaucoma therapy. Sight Sav. Rev. 42:213-221, 1972.
15. Hosoda, M., Yamabayashi, S., Furuta, M., and Tsukahara, S. Do glaucoma patients use eye drops correctly? J. Glaucoma 4:202-206, 1995.
16. Kass, M.A. Patient administration of eyedrops: Interview. Part I. Ann. Ophthalmol. 14:775-779, 1982.
17. Kass, M.A., Hodapp, E., Gordon, M., Kolker, A.E., and Goldberg I. Patient administration of eyedrops: Observation. Part II. Ann. Ophthalmol. 14:889-893, 1982.
18. Stewart, W.C., Hudgins, A.C., Pruitt, C.A., and Sine, C. Daily cost of newer glaucoma agents. J. Ocular Pharmacol. Ther. 15:379-388, 1999.
19. Stewart, W.C., Sine, C., Cate, E., Minno, G.E., and Hunt, H.H. Daily cost of β-adrenergic blocker therapy. Arch. Ophthalmol. 115:853-856, 1997.
20. Winfield, A.J, Jessiman, D., Williams, A., and Esakowitz L. A study of the causes of noncompliance by patients prescribed eyedrops. Br. J. Ophthalmol. 74:477-480, 1990.
21. Harris, A., Jonescu-Cuypers, C.P., Kagemann, L., Nowacki, E.A., Garozi, H., Cole, C., and Martin, B. Effect of dorzolamide timolol combination versus timolol 0.5% on ocular bloodflow in patients with primary open-angle glaucoma. Am. J. Ophthalmol. 132:490-495, 2001.
22. Orzalesi, N., Rossetti, L., Bottoli, A., Fumagalli, E., and Fogagnolo, P. The effect of latanoprost, brimonidine, and a fixed combination of timolol and dorzolamide on circadian intraocular pressure in patients with glaucoma or ocular hypertension. Arch. Ophthalmol. 121:453-457, 2003.